Customs (Prohibited Imports) Regulations (Amendment)

Administered by Attorney-General's Department

Legislation au F1996B03767 Regulations Not in force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

CUSTOMS (PROHIBITED IMPORTS) REGULATIONS (AMENDMENT)

STATUTORY RULES 1988 NO. 136

ISSUED BY THE AUTHORITY OF THE MINISTER OF STATE FOR SCIENCE, CUSTOMS AND SMALL BUSINESS

The Ministerial Council on Drug Strategy agreed at its November 1986 meeting that the Commonwealth, State and Territory Governments should take legislative action against drug analogues that have been known to be used in other countries as drugs of abuse and/or addiction. The Minister for Community Services and Health requested the addition of eleven such analogues to the Fourth Schedule to the Customs (Prohibited Imports) Regulations.

The Statutory Rules insert these analogues at new items 1, 1C, 1D, 8A, 8B, 76C, 76D, 76E, 93AAA, 104A and 120A.

The Statutory Rules also effect a consequential renumbering of existing items 1, 1A and 1B so that the relevant additions may be inserted in the correct alphabetical order.

Overview

The Customs (Prohibited Imports) Regulations (Amendment) Statutory Rules 1988 No. 136 were enacted to address the problem of drug analogues that were known to be used in other countries as drugs of abuse and addiction. This amendment was issued by the authority of the Minister of State for Science, Customs and Small Business, following the agreement of the Ministerial Council on Drug Strategy in November 1986 that legislative action was required. The policy objective was to enhance the regulation of dangerous substances by adding eleven specific drug analogues to the Fourth Schedule of the Customs (Prohibited Imports) Regulations, thus preventing their importation into Australia. The amendments also involved a consequential renumbering of certain existing items to ensure that the new additions were correctly placed in alphabetical order within the schedule.

Scope and Application

The Customs (Prohibited Imports) Regulations (Amendment) Statutory Rules 1988 No. 136 applies to the importation of drug analogues which have been identified as substances of abuse or addiction in other jurisdictions. These regulations were enacted following a decision by the Ministerial Council on Drug Strategy to address the issue of drug analogues through legislative measures at all levels of government. The regulations specifically target entities and individuals engaged in the importation of these substances, which are listed in the Fourth Schedule of the Customs (Prohibited Imports) Regulations, and are applicable across the Commonwealth of Australia. The regulations insert eleven new analogues into the Schedule, with a consequential renumbering of existing items to maintain an alphabetical order. Notably, these regulations do not specify exclusions, exemptions, or thresholds within the text provided, but their application may be further defined through subordinate instruments which are not detailed in the explanatory statement. The jurisdictional reach of these regulations is comprehensive, affecting all states and territories within Australia, reflecting a coordinated national approach to the regulation of prohibited imports.

Key Provisions

The main operative sections of these regulations, as referenced in Statutory Rules 1988 No. 136, primarily concern the amendment of the Customs (Prohibited Imports) Regulations to include new drug analogues in the Fourth Schedule. These additions are made at new items 1, 1C, 1D, 8A, 8B, 76C, 76D, 76E, 93AAA, 104A, and 120A. This action is in response to the Ministerial Council on Drug Strategy's agreement to address drug analogues known to be used as drugs of abuse and/or addiction in other countries. The regulations also involve a consequential renumbering of existing items to ensure that the new analogues are inserted in the correct alphabetical order. The obligations and requirements imposed by these regulations are primarily concerned with the importation of the newly listed drug analogues. Importers, exporters, and other relevant parties must now comply with the prohibitions against importing these substances, which are deemed to be controlled under the Customs Act 1901. The regulations mandate that these analogues are to be treated as prohibited imports, and any attempt to bring them into Australia will be subject to the same penalties as if they were the actual controlled drugs. The clear classification and listing of these analogues under the Fourth Schedule ensure that there is no ambiguity regarding the legal status of these substances. In terms of consequences for breach, the regulations stipulate that any contravention of the prohibitions against importing these drug analogues will result in significant legal repercussions. Under section 146 of the Customs Act 1901, an offence is created for the importation of these substances. The penalties for such offences can include substantial fines and, in serious cases, imprisonment. The maximum penalties are not explicitly stated in the Statutory Rules but are governed by the general provisions of the Customs Act, which can impose fines up to a significant amount and imprisonment for several years, depending on the severity of the offence and the value of the prohibited goods involved. Non-compliance with these regulations not only incurs criminal penalties but also civil penalties, including the confiscation of the imported goods and potential additional fines.

Legal classification tags

Area of Law
Drug Control Law
Instrument
Statutory Instrument
Concepts
Definitions & Interpretation
Reporting & Disclosure Obligations
Regulatory Standards

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.